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Cryptosporidium spp. infection in Iranian children and 
immunosuppressive patients: A systematic review and 
meta-analysis 
 
Abstract 
Background: Cryptosporidiosis is an important cause of diarrhea in children and 
immunosuppressive patients. The current study was intended to evaluate the prevalence 
rate of Cryptosporidium infection and clarify the epidemiological characteristics of the 
infection in both children and immunosuppressive patients in Iran. 
Methods: Five English electronic databases including PubMed, Google Scholar, Science 
Direct, Scopus and Cochrane, and two Persian language databases Magiran and Scientific 
Information Database were searched. Additionally, reports from the Iranian congresses of 
parasitology and graduate student thesis dissertations were assessed manually. 
Results: Out of 1856 studies from the literature search, our search resulted in a total of 27 
articles published from 1991 to 2016. These include 14 reports on cryptosporidiosis in 
children and 13 papers regarding immunosuppressive patients. 8520 children and 2015 
immunosuppressed cases were evaluated. Oocysts of Cryptosporidium were found in 3.8% 
and 8% children cases and immunosuppressed patients, respectively. There was a 
relatively high variation in the prevalence estimates among different studies, and the Q 
statistics was high among articles regarding children (p<0.0001) and also between records 
regarding immunosuppressed patients (p<0.0001). Findings showed that the prevalence 
rates of Cryptosporidium infection are significantly higher in children under 5 years 
(P=0.00). 
Conclusions: In summary, the present study provides a comprehensive view of the 
epidemiology of Cryptosporidium in children and immunosuppressive patients in Iran. 
Furthermore, a multidisciplinary and multicenter study to evaluate the real prevalence of 
Cryptosporidium infection and to determine its risk factors using an adequate sample size 
and standardized methods is highly recommended. 
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Cryptosporidiosis refers to the disease caused by several species of obligate, 
intracellular protozoan parasites known as Cryptosporidium. All species are able to infect
 
the microvilli border of the gastro-intestines and respiratory epithelium of
 
a variety of 
vertebrate hosts, including humans (1). A wide spectrum of clinical symptoms are 
observed in infected
 
individuals because the pathogenicity of Cryptosporidium varies in 
relation with the species
 
of parasites involved along with the age, and immune status of
 
the 
host (2). The main symptoms and signs are watery diarrhea, abdominal cramps, anorexia, 
weight loss, nausea, vomiting, fatigue and low-grade fever (2, 3). Cryptosporidiosis affects 
several groups of humans including children under five years and immunocompromised 
individuals, particularly HIV-infected patients (4).  
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Generally, this infection occurs following oocyst 
ingestion through the fecal–oral route. However, 
transmission of Cryptosporidium is complex and may occur 
from host to host (animal to human, person-to-person); 
through the ingestion of contaminated water or food and 
possibly airborne. Cryptosporidium produces resistant 
oocysts, like many other parasites which are passed in the 
feces into the environment.  These parasites have mechanical 
vectors such as insects or even birds which play a role in the 
transmission cycle (5, 6). Until now, thirty-one 
Cryptosporidium species have been recognized as valid, and 
of these, the most common species reported in humans 
throughout the world are C. parvum and C. hominis (1). This 
infection is highly prevalent and several factors contribute to 
the distribution of the parasite. These include shedding large 
numbers of oocysts from infected cases (7), resistance to the 
concentration and exposure times of disinfectants commonly 
used in the drinking water industry (5, 8), highly infectious 
oocysts (9) and the lack of treatment options (1). 
However, the prevalence and distribution of 
Cryptosporidium spp. infection in humans differs in 
geographic regions of the world and also within a country. In 
industrialized countries, the prevalence rate of 
cryptosporidiosis ranges from 0.1- 9.1% (10) and the most 
prevalent species is C. hominis (11, 12). In some developing 
countries, the prevalence rate of Cryptosporidium infection 
ranges from 2.98-25.9% and the most frequent species is C. 
hominis (13). In Iran, the range of cryptosporidiosis is 0.3 in 
children (14) to 26.7% in immunosuppressive patients (15).  
Nevertheless, there are some publications on 
cryptosporidiosis in Iran but no systematic review and meta-
analysis is available to describe the status of 
Cryptosporidium infection in this country. The current 
systematic review and meta-analysis was intended to 
evaluate the weighted prevalence of Cryptosporidium 
infection and clarify the epidemiological characteristics of 
the infection in both children and immunosuppressive 
patients in Iran.  
 
 
Methods 
Search strategy: To evaluate the epidemiological status of 
Cryptosporidium infection in humans in Iran, we designed a 
systematic review based on English and Persian literature 
released online articles published from 1991 to 2016. 
English electronic databases including PubMed, Google 
Scholar, Science Direct, Scopus and Cochrane, and two 
Persian language databases, Magiran and Scientific 
Information Database were searched. Additionally, reports 
from the Iranian parasitology congresses and graduate 
student dissertations were assessed manually. The current 
review was performed using medical subject headings 
(MeSH) terms including: “Cryptosporidium”, 
“Cryptosporidiosis”, “Prevalence”, “Epidemiology”, “Iran”, 
“Children” and “Immunosuppressive patients” alone or 
combined together. 
Study selection: All cross-sectional studies which estimated 
the prevalence of Cryptosporidium infection and 
cryptosporidiosis in children and immunosuppressive 
patients (HIV, severe kidney failure, cancers and multiple 
sclerosis patients) in the Iranian population were assessed in 
the current review. The criteria for the diagnosis of 
Cryptosporidium infection were based on staining, 
serological and molecular methods. All identified studies 
were imported to EndNote software to remove duplicates 
and were also independently assessed for eligibility and 
inclusion by both authors.  
Figure 1 shows how the studies were categorized and the 
reasons for exclusion. A total of 27 studies met the present 
study criteria, out of 1856 that were published as journal 
articles and presented in national conference proceedings and 
graduate student dissertations.  
Data extraction: All articles which met the criteria for 
inclusion were carefully investigated and information on 
population, sample size, age distribution, gender, 
Cryptosporidium diagnostic methods, and year of 
publication, study location, and number of subjects with 
positive test results were withdrawn using a data extraction 
form. Furthermore, data on human risk factors such as pet 
ownership, close contact with animals, occupational group, 
fruit or vegetable consumption, fruit and vegetable washing 
methods, place of residence, and educational level was 
collected. 
Statistical analysis: The prevalence in total and specific 
groups was calculated by age group, gender, residency and 
geographical region. In order to assess heterogeneity among 
the studies, a forest plot was used. The heterogeneity and 
quantifying variations were performed by statistical 
methods, I
2
 and Cochrane Q-statistics for the purpose of 
meta-analysis. A random effects model was employed as it 
assumed that the included studies were a random sample 
from a population of studies. The aforementioned plot 
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presented proportions of individual studies and overall 
prevalence. The trial version of StatsDirect statistical 
software was used to perform this meta-analysis 
(www.statsdirect.com). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flow diagram describing the study design process. 
 
 
Results 
Out of 1856 studies from the literature search, 14 articles 
regarding children and 13 records about immunosuppressed 
patients were considered appropriate for inclusion in this 
systematic review and meta-analysis. Table 1 shows the 
results of the literature search on demographic data 
associated with the prevalence of Cryptosporidium infection 
in Iranian children.  In total, 8520 child cases and  
2015 immunosuppressed individuals were included in the 
current study.   
 
 
 
 
Oocysts of Cryptosporidium were found in 294 and 125 of 
child cases and immunosuppressed patients, respectively. 
There was a relatively high variation in the prevalence 
estimates among the different studies, and the Q statistic was 
high among articles regarding children (Q=51.87, df=14, 
p<0.0001; I2= 74.9% (95% CI=54.1% to 83.9%) and also 
between records regarding immunosuppressed patients 
(Q=151.9, df=12, p<0.0001; I2=92.1% (95% CI=88.8% to 
94.1%)) (figures 2, 3). 
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(A)                                                                                (B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Forest plot diagram (A) and bias assessment graph (B) of 14 studies showing the prevalence rates of Cryptosporidium infection 
in Iranian children (first author, year and province of study).  
 
 
 
(A)                                                                                                     (B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Forest plot diagram (A) and bias assessment graph (B) of 13 studies showing the prevalence rates of 
Cryptosporidium infection in Iranian immunosuppressive patients (first author, year and province of study). 
 
Modified Ziehl-Neelsen technique and enzyme-linked 
immunosorbent assay (ELISA) were used in the included  
studies. Molecular methods were also used in some studies  
 
to confirm the results of the Ziehl-Neelsen technique or to 
genotype the parasite. Results of the meta-analysis showed 
that the prevalence rates of Cryptosporidium infection in 
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children under 5-years old are higher than children over 5-
years old (4.21% versus 1.22%, respectively; P=0.000). 
Considering stool form, positive rate in the diarrheal stool 
and both diarrheal and non-diarrheal cases was 4.03% and 
1.1% (P=0.000). The results of the literature search on 
demographic data associated to the prevalence of 
Cryptosporidium infection in Iranian children are shown in 
table 1.  The results of this meta-analysis showed that the 
average of Cryptosporidium infection rate was higher in 
immunosuppressive cases (8%), in comparison with children 
(3.8%) (P= 0.038, 95% CI= -8.856041 to 0.460436). A 
possible association between Cryptosporidium infection and 
gender was evaluated in 10 out of 27 studies. The mean and 
standard deviation of prevalence in males and female cases 
were 5.52%±2.5 and 4.72±3.2, respectively (P=0.5). In the 
children group, the mean and standard deviation of 
prevalence was 4.83±2.2 in males and 3.52±1.4 in females 
(P=0.29). In the immunosuppressive patient group, the mean 
and standard deviation of prevalence rates were 6.22±2.8 and 
5.92±4.2 (P=0.9) in male and female cases, respectively. 
 
Table 1. Demographic data in relation to prevalence of Cryptosporidium infection in Iranian children.  
 
Variables Participants Positive cases Prevalence P-value References 
Gender 
Male  
Female 
 
2001 
1629 
 
77 
84 
 
3.85 
5.2 
 
0.062 
 
28, 44, 46, 47, 
49, 51, 52 
Age 
<5 
>5 
 
3495 
982 
 
147 
12 
 
4.21 
1.22 
 
0.000 
 
 
14, 28, 44,45, 46, 47,49, 51, 52 
Form of stool 
Diarrheic 
Non-diarrheic 
 
2456 
798 
 
99 
9 
 
4.03 
1.1 
 
0.000 
 
14, 28, 44,45, 46, 47,49, 51, 52 
Residency 
Urban 
Rural 
 
878 
493 
 
12 
6 
 
1.4 
1.2 
 
0.515 
 
14, 49 
Animal contact 
Yes 
No 
 
86 
685 
 
10 
11 
 
11.6 
1.6 
0.000 46, 47 
Seasons 
Spring 
Summer 
Autumn 
Winter 
 
283 
178 
287 
156 
 
24 
11 
35 
8 
 
8.5 
6.2 
12.2 
5.1 
 
0.038 
 
28, 44 
 
Discussion 
Human cryptosporidiosis is an important zoonotic 
infection that causes diarrhea in immunocompromised 
individuals and children. It also causes extra-intestinal 
infection in severe immunodeficiency (2). This systematic 
review and meta-analysis study gives a general estimate for 
the prevalence of Cryptosporidium in children and 
immunosuppressive patients in Iran. The overall prevalence 
obtained in the aforementioned population was relatively 
high (6%). The prevalence rates of the infection with regard 
to children and immunosuppressive cases were 3.8% 
 
 
and 8%, respectively. The total prevalence (6%) was 
approximately similar to some studies conducted in Malaysia 
(5.2%) (16), South Africa (5.59%) (17). Higher rates of 
infections have been reported in other studies such as in 
Afghanistan (14.1%) (18), Palestine (11.5%) (19), Jordan 
(8.3%) (20), India (12%) (21), Saudi Arabia (11%) (22) and 
Pakistan (10.9%) (23); and the lower rate of infection has 
been reported in Kenya (4%) (24) and North-West Ethiopia 
(4.6%) (25). Moreover, the prevalence rates of 
Cryptosporidium infection have been reported as less than 1 
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percent to more than 30 percent worldwide (26). In 2012, 
Fletcher et al. reviewed the relative prevalence of 
Cryptosporidium spp. in several developed countries and 
revealed that the relative prevalence rate of this infection 
ranges from 0.1% to 9.1% of cases. They also reported that 
Cryptosporidium infection is responsible for about 20% of 
diarrheal episodes in children in developing countries and up 
to 9% of episodes in developed regions (10). In fact, global 
Cryptosporidium infection distribution has been associated 
with various risk factors but its risk factors in developing 
nations are very different to those in industrialized countries 
(3). These risk factors include situation of sanitation, health 
status, exposure to pets and animals, nutritional behavior 
(consumption of raw vegetables and contaminated drinking 
water), unsafe sexual activity, geographical climate, and 
location of residence (3, 27).  
Our study results reveal that there is a high prevalence 
rate of Cryptosporidium infection in children (13.1%) in 
Bushehr (28), and immunosuppressive patients (26.7%) in 
Hamedan (15). It also demonstrated low prevalence of this 
infection in children (0.3%) in Qazveen (14), and 
immunosuppressive patients (0.56%) in Hamedan (29). A 
disagreement in the prevalence of Cryptosporidium infection 
in immunosuppressive patients is seen in Hamedan. A 
possible explanation is the type of the studied population and 
time. Taherkhani et al., 2007 studied HIV patients and Jafari 
et al., in 2014 evaluated renal transplantation cases. 
However, the prevalence of Cryptosporidium infection, like 
other intestinal infections, is closely related to cultural, 
environmental, social and economic factors (30). 
Our data shows that Cryptosporidium prevalence in 
children under five years old (4.21%) was significantly 
higher than children above five years old (1.2%). These 
findings are supported by various studies which demonstrate 
that Cryptosporidium infections occur frequently in children 
under than 5 years where the peak of infections and diarrhea 
appear in children younger than 2 years old (31, 32).  
In regard to diarrhea in 4/14 studies evaluated, 
Cryptosporidium infections in both diarrheic and non-
diarrheic children found that the prevalence of this infection 
are significantly higher in diarrheic cases. Overall, the 
statistical analysis of 9 studies showed that the prevalence 
rate of Cryptosporidium infection was significantly higher in 
diarrheic children compared with non-diarrheic children 
(table 1). These findings are in line with several studies, 
indicating that this parasite is one of most important causes 
of diarrhea-associated pathogens in children (33, 34).  
Our data showed that the Cryptosporidium prevalence 
rate is slightly higher in male cases than in female subjects 
and no significant difference was observed between the two 
sexes. A study reviewed cryptosporidiosis in developing 
countries and indicated that no significant differences were 
observed by sex in Kenya (13). The study of Painter et al., in 
the United States showed that the rates of cryptosporidiosis 
were higher among males than females in cases under15 
years old. In contrast, cryptosporidiosis rates were higher 
among females aged ≥15 years (35). 
This meta-analysis study was suffering from inadequate 
analysis for the prevalence of Cryptosporidium infections 
regarding contact with animals, level of education, 
occupation, residency, fruit or vegetable consumption, fruit 
and vegetable washing methods, and season. Therefore, the 
risk factors associated to cryptosporidiosis are not well 
known in Iran and indeed the roles of humans, livestock and 
wildlife in the Cryptosporidium transmission cycle remain 
largely unknown.  
Different methods for the detection of Cryptosporidium 
infections are used globally. The most common techniques 
are microscopic, immunological and molecular methods (36, 
37). Our data showed that the microscopy method, acid-fast 
Ziehl-Neelsen (ZN), was the most common assay. Three and 
six studies used enzyme immunoassay test and molecular 
methods, respectively. The molecular assays revealed that C. 
parvum (84.4%) is the most common species found in 
human cases in Iran, followed by C. hominis (13.74). These 
findings are supported by some studies indicating that C. 
parvum and C. hominis are the most prevalent species in 
humans and that C. parvum is the dominant species (1, 38, 
39). In contrast, several studies demonstrated that C. hominis 
is the most prevalent species in humans (7, 13, 40). Yet, the 
distribution of cryptosporidium species in humans is 
different amongst geographic regions and socioeconomic 
conditions. For example, both C. hominis and C. parvum are 
the commonly detected species in humans, in European 
countries and New Zealand but C. parvum is the dominant 
species found in humans in the Middle Eastern countries (7, 
39). Only one study reported C. meleagridis in a child (one 
out of 16 positive cases) (Rafiei et al., 2014). C. meleagridis 
infection in a child in Mazandaran province, northern Iran 
was first reported in our previous study, focused on the 
molecular epidemiology of Cryptosporidium spp. in some 
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developing countries and in the United Kingdom using 
restriction fragment length polymorphism (PCR-RFLP) and 
sequencing of the 18S rRNA gene (40), and PCR-RFLP and 
sequencing of Cryptosporidium oocyst wall protein (COWP) 
and 70-kDa heat shock protein (HSP70) genes (41). 
In conclusion, to the best of our knowledge, the present 
study provides a comprehensive view of the epidemiology of 
Cryptosporidium in children and immunosuppressive 
patients in Iran. 
 Immunosuppressive individuals show a two-fold higher 
prevalence rate than children and also Cryptosporidium 
infection is more prevalent in diarrheic patients compared 
with non-diarrheic cases. The current study suggests that 
these patients should be monitored regularly. It is also 
suggested that a multidisciplinary and multicenter study to 
evaluate the real prevalence of Cryptosporidium infection 
and to determine its risk factors using adequate sample size 
and standardized methods should be performed in Iran. 
Furthermore, the continuous monitoring of Cryptosporidium 
in surface water, livestock, wildlife, and humans using 
appropriate methods particularly molecular techniques 
would be helpful to increase our understanding of infection 
and transmission patterns of this parasite in Iran.  
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